Intellectia News
Welcome to the Pulse of Finance - Your Daily News Digest
11
Beam Therapeutics Reports Promising Results for BEAM-103 in Sickle Cell Disease
Intellectia.AI12 days ago
5
Cogent Biosciences Advances Bezuclastinib Trials for Systemic Mastocytosis
Intellectia.AI12 days ago
9
Acimtamig (AFM13) Advances in Treating CD30-Positive Tumors
Intellectia.AI12 days ago
6
bluebird bio's LYFGENIA: Pregnancy, Reproductive Guidelines, and Company Overview
Intellectia.AI12 days ago
6
Merck Advances Zilovertamab Vedotin Trials in B-Cell Malignancies
Intellectia.AI12 days ago
14
Novartis Reports Superior Efficacy of Scemblix in Phase 3 Trial
Intellectia.AI12 days ago
6
CASGEVY Treatment and Vertex Pharmaceuticals: A Comprehensive Overview
Intellectia.AI12 days ago
7
Gilead and Kite Report Adverse Reactions in CAR T-cell Therapy Trials
Intellectia.AI12 days ago
10
Five9 Nears Settlement with Anson Funds Amid Activist Pressure
Intellectia.AI12 days ago
6
DISC-0974 Trials for Myelofibrosis and Chronic Kidney Disease Anemia
Intellectia.AI12 days ago
4
Methode Electronics Reports Strong Earnings, Analysts Raise Price Target
Intellectia.AI12 days ago
5
AstraZeneca Advances Hematology and Oncology Programs with CALQUENCE and AMPLIFY Trial
Intellectia.AI12 days ago